The information highlighted (if any) are the most recent updates for this brand.
Irbesartan is contraindicated in patients with hypersensitivity to this drug and its components and history of hypersensitivity to Angiotensin II type 1 (AT1) receptor antagonist. Do not use the drug in pregnant women in second and third semester; and also in nursing mother.